Daniels Mark 4
4 · Twist Bioscience Corp · Filed Mar 5, 2021
Insider Transaction Report
Form 4
Daniels Mark
Chief Compliance Officer & GC
Transactions
- Exercise/Conversion
Common Stock
2021-03-04$10.70/sh+669$7,158→ 67,595 total - Sale
Common Stock
2021-03-04$125.33/sh−669$83,846→ 66,926 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-03-04−669→ 6,685 totalExercise: $10.70Exp: 2028-02-01→ Common Stock (669 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020.
- [F2]The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.